|
Volumn 8, Issue 11, 2001, Pages 963-967
|
Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase
a b b a a,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 HYDROXYTRYPTOPHAN;
BENSERAZIDE;
CARBIDOPA;
CATECHOL;
DOPA DECARBOXYLASE INHIBITOR;
HYDRAZONE DERIVATIVE;
LEVODOPA;
ARTICLE;
CRYSTAL STRUCTURE;
ENZYME ACTIVE SITE;
ENZYME BINDING;
ENZYME INHIBITION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
5-HYDROXYTRYPTOPHAN;
ANIMALS;
ANTIPARKINSON AGENTS;
BENSERAZIDE;
BINDING SITES;
CARBIDOPA;
CRYSTALLOGRAPHY, X-RAY;
DOPA DECARBOXYLASE;
DRUG DESIGN;
HUMANS;
KIDNEY;
LEVODOPA;
LIGANDS;
MODELS, MOLECULAR;
PARKINSON DISEASE;
PLIABILITY;
PROTEIN STRUCTURE, SECONDARY;
SWINE;
|
EID: 0034753414
PISSN: 10728368
EISSN: None
Source Type: Journal
DOI: 10.1038/nsb1101-963 Document Type: Article |
Times cited : (200)
|
References (51)
|